Literature DB >> 3484511

Direct interactions between B and T lymphocytes bearing complementary receptors.

J P Tite, J Kaye, K M Saizawa, J Ming, M E Katz, L A Smith, C A Janeway.   

Abstract

A murine cloned Th cell line specific for the antigen conalbumin in the context of self I-A molecules can be activated by low concentrations of soluble antireceptor mAb. By using an antireceptor mAb to shared antigenic determinants on T cell receptors, we have shown that the ability to be activated by soluble antireceptor mAb is an unusual, although not unique, feature of this cloned T cell line. This activation does not involve occult APC, FcR, or interaction between individual cloned T cells, as limiting-dilution analysis shows that individual cells of this clone will grow in the presence of the antireceptor antibody and IL-1 as stimulus. This cloned T cell line is highly immunogenic in vivo, giving rise to antireceptor antibodies that stimulate its growth in both mice and rats. This response is not dependent upon exogenous T cells. Rather, the clone directly interacts with complementary B cells, as shown by the production of mAb in nude mice, and by production of stimulating antireceptor antibodies by purified B cells cultured with cloned Th cells in vitro. Several features of this cloned Th cell line, most especially its ability to be activated, rather than inhibited, by antireceptor antibodies, may account for its striking ability to directly activate B cells bearing complementary receptors. The direct interaction of the cloned Th cell with B cells bearing complementary receptors may serve as a model for receptor-receptor interactions in the generation of both T and B cell repertoires.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484511      PMCID: PMC2188016          DOI: 10.1084/jem.163.1.189

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  Protein-antigen specific Ia-restricted cytolytic T cells: analysis of frequency, target cell susceptibility, and mechanism of cytolysis.

Authors:  J P Tite; M B Powell; N H Ruddle
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

2.  The immunobiology of T cell responses to Mls-locus-disparate stimulator cells. II. Effects of Mls-locus-disparate stimulator cells on cloned, protein antigen-specific, Ia-restricted T cell lines.

Authors:  M E Katz; C A Janeway
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

3.  Idiotype-specific T helper cells are required to induce idiotype-positive B memory cells to secrete antibody.

Authors:  R Woodland; H Cantor
Journal:  Eur J Immunol       Date:  1978-08       Impact factor: 5.532

4.  Cloned helper T cells can kill B lymphoma cells in the presence of specific antigen: Ia restriction and cognate vs. noncognate interactions in cytolysis.

Authors:  J P Tite; C A Janeway
Journal:  Eur J Immunol       Date:  1984-10       Impact factor: 5.532

5.  Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes.

Authors:  D M Kranz; S Tonegawa; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

6.  A cloned, antigen-specific, Ia-restricted Lyt-1+,2- T cell with suppressive activity.

Authors:  K Bottomly; J Kaye; B Jones; F Jones; C A Janeway
Journal:  J Mol Cell Immunol       Date:  1983

7.  Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor.

Authors:  U D Staerz; H G Rammensee; J D Benedetto; M J Bevan
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

8.  Distinct functional phenotypes of cloned Ia-restricted helper T cells.

Authors:  J Kim; A Woods; E Becker-Dunn; K Bottomly
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

9.  The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype.

Authors:  K Haskins; C Hannum; J White; N Roehm; R Kubo; J Kappler; P Marrack
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

10.  Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. 3. Analysis of mechanism.

Authors:  N H Ruddle; B H Waksman
Journal:  J Exp Med       Date:  1968-12-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes.

Authors:  Christiane S Hampe
Journal:  Autoimmunity       Date:  2012-02-23       Impact factor: 2.815

2.  B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells.

Authors:  S Weiss; B Bogen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  Turning (Ir gene) low responders into high responders by antibody manipulation of the developing immune system.

Authors:  C Martinz; M A Marcos; P Pereira; C Marquez; M Toribio; A de la Hera; P A Cazenave; A Coutinho
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

4.  In vivo effects of anti-idiotype on Plasmodium chabaudi infection in mice.

Authors:  M J Moore; F C Hay; J Wood; K N Brown
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

5.  Molecular dynamics in the membranes of helper T cells.

Authors:  A Kupfer; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  The specific interaction of helper T cells and antigen-presenting B cells. IV. Membrane and cytoskeletal reorganizations in the bound T cell as a function of antigen dose.

Authors:  A Kupfer; S J Singer
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

7.  Genetic and immunochemical evidence for CD4-dependent association of p56lck with the alpha beta T-cell receptor (TCR): regulation of TCR-induced activation.

Authors:  R Díez-Orejas; S Ballester; M J Feito; G Ojeda; G Criado; M Ronda; P Portolés; J M Rojo
Journal:  EMBO J       Date:  1994-01-01       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.